Home › Funds › Kintegral Advisory, LLC › CVS

Kintegral Advisory, LLC position in CVS

CVS HEALTH CORP · Consumer Staples

Kintegral Advisory, LLC reported holding 61,479 shares of CVS (CVS HEALTH CORP) in its Q2 2026 13F filing — a position valued at US$6.4M, representing 0.52% of its reported portfolio and ranking #44 among its reported holdings. Kintegral Advisory, LLC first reported this position in Q2 2026.

Latest position (Q2 2026)61.48K sh
Reported value held$6.36M
Portfolio Weight0.52%
First reportedQ2 2026
Last changeNew

How Kintegral Advisory, LLC's CVS position evolved

Kintegral Advisory, LLC first disclosed a stake in CVS in Q2 2026 at 61,479 shares (US$6.4M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 61.48K $6.36M New

About CVS and 13F data

CVS (CVS HEALTH CORP) is a Consumer Staples company. 213 other funds we track also report a position in CVS — the largest reported positions include BlackRock Inc (US$12.75B), Vanguard Group (US$9.58B), VANGUARD CAPITAL MANAGEMENT LLC (US$8.62B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CVS

All CVS fund holders →